PolyPeptide Group AG (SWX: PPGN)

PolyPeptide Group AG Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue Growth (YoY)	-69.93%	-26.08%	25.50%	58.06%	23.47%	-45.54%
Asset Writedown	19.52	12	-1.6	32.27	13.37	16.63
Pretax Income	86.09	99.23	185.61	187.29	98.77	79.08
Income Tax Expense	3.65	16.72	40.14	43.05	20.41	8.07
Net Income	82.44	82.5	145.47	144.24	78.36	71.01
Net Income to Common	82.44	82.5	145.47	144.24	78.36	71.01
Net Income Growth	-49.06%	-43.28%	0.85%	84.08%	10.35%	-40.63%
Shares Outstanding (Basic)	9	9	9	9	9	10
Shares Outstanding (Diluted)	9	9	9	9	9	10
Shares Change (YoY)	0.00%	-0.93%	-2.07%	1.04%	-1.15%	-4.83%
EPS (Basic)	8.94	8.95	15.64	15.18	8.33	7.47
EPS (Diluted)	8.94	8.95	15.64	15.18	8.33	7.47
EPS Growth	-49.05%	-42.75%	2.98%	82.18%	11.63%	-37.62%
Free Cash Flow	42.01	81.17	4.89	33.35	45.63	36.02
Free Cash Flow Per Share	4.56	8.81	0.53	3.51	4.85	3.79
Dividend Per Share	5.500	5.500	5.000	5.000	5.000	5.000
Dividend Growth	10.00%	10.00%	0%	0%	0%	13.64%
Operating Margin	77.87%	54.16%	83.02%	87.78%	80.33%	76.06%
Profit Margin	87.84%	47.95%	62.50%	77.77%	66.78%	74.72%
Free Cash Flow Margin	44.76%	47.18%	2.10%	17.98%	38.89%	37.91%
EBITDA	73.17	93.3	193.36	162.94	94.39	72.4
EBITDA Margin	77.97%	54.23%	83.08%	87.86%	80.45%	76.19%
D&A For EBITDA	0.1	0.13	0.13	0.14	0.14	0.13
EBIT	73.08	93.18	193.23	162.81	94.25	72.27
EBIT Margin	77.87%	54.16%	83.02%	87.78%	80.33%	76.06%
Effective Tax Rate	4.24%	16.85%	21.63%	22.99%	20.67%	10.20%
Revenue as Reported	93.85	172.05	232.75	185.46	117.33	95.03

Source: S&P Capital IQ. Standard template. Financial Sources.